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During pregnancy, both ischemic reperfusion and bacterial agent LPS are known risk factors for fetal
brain damage. However, there is a lack of evidence to explain whether vaginal LPS affects the fetus
response to ischemic reperfusion. Here we reported that there was more than 2 folds higher vulnerability
of fetal brain hemorrhage response to ischemic reperfusion when mother mouse was treated with
vaginal LPS. As our previously reported, ischemic reperfusion induces P53-dependent fetal brain damage
was based on a molecular mechanism: the transcriptional pattern was changed from HIF-1alpha-
dependent to P53-dependent immediately. In the present work, only with vaginal LPS precondition,
phosphorylation of activated transcriptional factor (ATF) 2 at Thr71 appeared in response to ischemic
reperfusion. Moreover, this phosphorylation was completely blocked by pre-treatment with a P53 in-
hibitor, piﬁthrin-a. We concluded that vaginal LPS precondition trigged the p53-dependent phosphor-
ylation of ATF2 in response to ischemic reperfusion, which played an important role of increasing
vulnerability to hemorrhage in fetus.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Fetal brain damage induces pregnancy loss or severe diseases
like cerebral palsy. Ischemic reperfusion is a risk factor of fetal brain
damage in the late preterm period during pregnancy. Ischemic
reperfusion in pregnant women is usually caused by intrauterine
asphyxia [1]. However, ~70% pregnant women have experiences on
bacterial vaginosis (BV) including subclinical BV [2,3] a risk factor of
preterm birth and fetal brain damage [4e6]. Expose to both
ischemic reperfusion and subclinical BV during pregnancy is not
rare. However, there is no answer to only a simple question
“whether vaginal inﬂammation derived from subclinical BV has
effect on fetal brain damage”. In the present work, we ﬁrst inves-
tigated whether vaginal bacterial lipopolysaccharide (LPS) effectsvation and Education Center,
a, Sendai, Miyagi 980-8574,
g).
Inc. This is an open access article ufetal response to ischemic reperfusion.
Fetal brain damage varies according to the stage of brain
development and the method of ischemic reperfusion or LPS in-
duction. Animal experimental data has shown that either Ischemic
reperfusion (20 min) or extra-uterine LPS (0.3 mg/kg i.p.) exposure
fails to induce fetal brain damage whereas intra-uterine LPS
exposure prior to birth causes a normal neuronal dopamine
reduction [4,5]. Moreover, LPS given 4 h prior to Ischemic reper-
fusion produces infarction in brains of 7-day-old rat pups [6].
Therefore, all these imply that LPS sensitizes the immature brain to
Ischemic reperfusion. However, it is still unknownwhether vaginal
LPS administration induces the fetal brain damage response to
ischemic reperfusion.
LPS induces an inﬂammatory reaction via activating a wide
range of signaling pathways such as the mitogen-activated protein
kinases (MAPKs) and Akt pathways. MAPKs mainly include extra-
cellular signal regulated kinase (ERK), P38 and c-Jun N-terminal
kinase (JNK). Phosphorylated forms of these proteins regulate
various target genes including p53 and activate transcriptionalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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are proven to be dependent on their phosphorylation [10,11]. P53-
dependent cell death has known to play an important role during
development and various types of brain damage such as sub-
arachnoid hemorrhage [12e15]. As our previous report [16],
response to IR, P53 was a central molecular response to immedi-
ately regulate the gene expression within 30 min after ischemic
reperfusion. Moreover, current evidence shows that pretreatment
with piﬁthrin-a (PFT-a) can reduce ischemic brain injury through
p53 transcriptional activity inhibition in mice [14,15]. On the other
hand, phosphorylation of ATF2 at Thr71 was recorded in adult rat
brain response to various stresses such as osmotic stress and
transient cerebral ischemic reperfusion [17,18].
2. Materials and methods
All animal experiments in this study were conducted in accor-
dance to the Tohoku University guidelines for animal experimen-
tation. The Tohoku University Committee for SafetyManagement of
Animals approved all the experimental protocols in this study.
2.1. Mice
C57BL/6N mice were used for all experiments. Mice were pur-
chased from CLEA Japan Inc. (Japan). Mice weighing 18e22 g (9e14
weeks) were bred overnight marking gestation day 0 (GD 0) under
speciﬁc pathogen-free conditions at the Animal Research Institute
of Tohoku University. Speciﬁcally for the sacriﬁce/euthanasia,
anesthesized mice was be killed by using ketamine (Ketalar
500 mg®Daiichi-Sankyo: 100 mg/kg) and xylazine (ROMPUN INJ.
SOLUTION 2%®Bayer; 10 mg/kg).
Every day, body weight and food intake of pregnant mice were
measured, there were no signiﬁcant changes between all groups.
2.2. Inﬂammation induced by LPS administration
To induce vaginal inﬂammation during the late gestational
period, LPS administration was selected to start on GD14 in our
murine model (Supplementary Fig. 1a). Either vaginal saline or
amniotic LPS (10 ml of 1 mg/ml per fetus) was used as a control.
Vaginal LPS was administered as previously described [21].
Speciﬁcally, 0.3, 3 or 30 mg/vagina of LPS was administered twice on
GD14 and GD16. During these dates, GD14 to GD18, that body
weight is observed to increase, such as from 31.8 ±
1.2 ge37.9 g ± 0.8 g (n ¼ 3 dams). During this period, there is ac-
celeration of the fetal brain development in humans [22]. Our data
has shown that 30 mg LPS using current method induced premature
birth (2/5 dams). Thus, we adopted the conﬁrmed LPS concentra-
tion of 3 mg/vagina to induce a subclinical inﬂammatory in vagina
without premature birth. However, only a single administration of
3 mg vaginal LPS on GD14 produced no inﬂammatory cells in the
vagina on GD18 as detected by Hematoxylin and Eosin staining,
therefore a continuous administration through to GD16 was
necessary to maintain local inﬂammation until GD18, the day of IR
treatment. Double LPS administration in the vagina every two days
from GD14 was performed to replicate an antenatal infective
process.
2.3. Intrauterine ischemic reperfusion
In present work, ischemic reperfusion was induced on GD18 as
previously described [16]. Because ischemic reperfusion in preg-
nant women is usually caused by intrauterine asphyxia [1], such as
in the case of women in labor wherein uterine contractions cause
ischemia and uterine relaxation allows reperfusion. Asepticconditions were maintained all throughout the experiment. During
the surgery, temperature was controlled at 36.5 ± 1 and humidity
at 65 ± 5%.
2.4. P53 inhibitor pre-treatment
To inhibit P53 activity in the fetal brain, Piﬁthrin (PFT)-a
(sc222176, SANTA CRUZ) was administered as previously described
[16]. Speciﬁcally, a single subcutaneous (s.c.) injection was
administered 3 or 6 h (described as 3 or 6 in the Supplementary
information) prior to ischemic reperfusion on day 18 of gestation
(GD18).
2.5. Fetal brain population
Pregnant mice were separated into six conditions: 1. No vaginal
treatment (n ¼ 10); 2. Vaginal saline administration (saline:
n ¼ 10); 3. Vaginal LPS administration (LPS: n ¼ 52); 4. Only
ischemic reperfusion by clipping of a unilateral uterine horn for a
total of 15 min on GD18 (IR: n¼ 12); 5. Vaginal saline plus ischemic
reperfusion (n ¼ 16); 6. Vaginal LPS plus ischemic reperfusion
(n ¼ 54). Brain samples were derived from 190 fetuses from 52
mouse dams.
Fetal brain sampling was performed on GD18. In study condi-
tions involving fetal brain ischemic reperfusion, samples were
immediately collected after reperfusion and all steps of sampling
were ﬁnished within 30 min.
2.6. Sections and imaging
To evaluate LPS induced inﬂammation, vagina and brain sam-
ples were dissected and ﬁxed for 3 days in 15 ml of 4% para-
formaldehyde (PFA) or frozen immediately using dry ice. Parafﬁn-
embedded samples (3 mm) were analyzed by Hematoxylin and
eosin (HE) staining.
To evaluate the vulnerability of fetal brain hemorrhage, micro-
scopic examination of frozen brains samples in 10 mm sections were
used to ascertain evidence with HE staining as control.
2.7. RT-PCR
Total mRNA extracted from 5 fetal brains from each treatment
group were utilized. RT-PCR primers were designed by Primer3Plus
software. The sequences used as primers have been provided as
Supplementary Table 1.
2.8. Western blotting
We investigated protein changes within 30 min after IR in the
fetal brain.
As previous report [16], for western blot analysis, tissues were
ﬂash-frozen in liquid nitrogen and stored at 80 until use.
Antibodies (1:1000) used were purchased from Cell Signaling
Technology: Anti-Actin (5125), anti-TLR4 (2219), anti-phospho
rylation of ERK1/2 at Thr202/Tyr204 (4376), anti-phosphorylation of
p38 at Thr180/Tyr182 (9211), anti-phosphorylation of AKT at Ser473
(4060), anti-SAPK/JNK (9258), anti-phosphorylation of SAMP/JNK at
Thr183/Tyr185 (4668), and anti-phosphorylation of ATF2 at Thr71
(9221).
Western blot data were analyzed using Image J software. Graphs
were made and analyzed using Graphpad Prism 5 software.
2.9. ELISA
A blood sample was collected into a pre-cooled EDTA tube. For
Y. Dong et al. / Biochemical and Biophysical Research Communications 468 (2015) 228e233230amniotic ﬂuid samples, those from fetuses from the same mother
were mixed and collected into a 1.5 ml tube. All samples were
immediately centrifuged at 2200 g for 15 min at 4 C. The super-
natants were stored at 80 C until analysis. The mouse inﬂam-
matory cytokines multi-analyte ELISArray kit (MEM-004A,
SABiosciences QIAGEN) was used to detect 12 types of pro-
inﬂammatory cytokines in the plasma or amniotic ﬂuid samples.
The cytokines included in the array are IL1A, IL1B, IL2, IL4, IL6, IL10,
IL12, IL17A, IFNg, TNFa, G-CSF, and GM-CSF.
2.10. Fetal electrocardiography (FECG)
As a previous report [16,23,24], FECG was used to evaluate the
situation of fetuses (PCT/JP2006/316386). Speciﬁcally, if necessary,
FECG was continuously measured within 3 h after ischemic
reperfusion.
2.11. Statistical analysis
Parameters derived were expressed in mean ± standard devia-
tion (SD). The statistical method used was the Student's t test (two
tailed for independent samples) for two group comparison. For
multiple group comparison, statistical analysis was performed us-
ing the KruskaleWallis one-way ANOVA. A probability (p) of less
than 0.05 was considered signiﬁcant.
3. Results
3.1. Vaginal LPS may sensitize the fetal brain response to ischemic
reperfusion
Fetal hemorrhage has been considered as a major etiology of
cerebral palsy, speciﬁcally in the late gestation [5,19,20]. To inves-
tigate whether vaginal LPS is a risk factor for fetal brain damage
when exposed to ischemic reperfusion (IR), intracerebral hemor-
rhage incidencewas investigated. According to a grading system for
fetal hemorrhage [25], most cases in the vaginal LPS plus IR group
were classiﬁed as Grade I (Fig. 1d). Within 30 min post-IR, LPS
administration notably increased the vulnerability of hemorrhage
due to IR from 2/8 to 7/13 (Fig. 1e). This result implies that the risk
of intracerebral hemorrhage is higher (25% Vs 53.8%) with vaginal
LPS precondition. This is in agreement with previous studies [6,30],
where Vaginal LPS also sensitized the immature brain response to
IR.
3.2. Vaginal LPS induced a signiﬁcant local inﬂammation and
increased phosphorylation of JNK response to ischemic reperfusion
in the fetal brain
To evaluate the inﬂammation induced by vaginal LPS, vagina
was collected on GD18 and analyzed by HE staining (Fig. 2a). In-
ﬂammatory cells speciﬁcally appeared at the junction between the
vagina and uterus in the LPS treated mice. Using fetal electrocar-
diograph, it has been shown that vaginal LPS did not signiﬁcant
change the character of heart beat rate response to 3 cycles of 5 min
ischemic reperfusion [16] (Fig. 2beh). Under vaginal LPS precon-
dition, Ischemia reduced heart beat rate, oxygen concentration in
the amniotic ﬂuid, and phosphorylation of proteins including Akt at
Thr202/Tyr204 and Erk at Ser473 (Fig. 2i, Supplementary Fig. 1a),
while reperfusion rescued heart beat rate immediately. On this
endpoint time, 12 types of cytokines (see material and methods),
including IL-6, TNF and G-CSF were found to be negative in the
plasma of mouse dams (Fig. 2k, comparewith amniotic LPS induced
positive cytokine release in Supplementary Fig. 1b).
On the other hand, phosphorylation of JNK1/2 at Thr183/Tyr185was increased in the LPS plus IR group (Fig. 3a). As our previously
report [16], IR inhibits most protein phosphorylation activity [1], so
that increased phosphorylation of JNK1/2 was of primary focus in
this study.
3.3. Quick phosphorylation of ATF2 at Thr71 needs both LPS and
ischemic reperfusion
Stress-inducible transcriptional factor ATF2 is a known substrate
of MAPKs and its phosphorylation is enhanced by JNK activation
[9,26e28]. In mice, ATF2 is highly expressed and activated in the
brain and it plays a critical role in mouse embryos [29]. Only under
vaginal LPS precondition, phosphorylation of ATF2 was strongly
detected response to IR (Fig. 3a). Next, we conﬁrmed that phos-
phorylation of ATF2 was not caused by experimental stimuli or was
not due to LPS alone. Either only ischemic reperfusion, only vaginal
LPS (even 30 mg LPS in Fig. 3c; the last lane from left), vaginal saline
plus ischemic reperfusion (Fig. 3a; lane 4), or only a single vaginal
administration of 3 mg LPS on GD14 (Supplementary Fig.1c), they all
did not induced detectable phosphorylation of ATF2 at Thr71.
3.4. Piﬁthrin (PFT)-a suppressed phosphorylation of ATF2 in LPS
groups
Ischemic reperfusion immediately changed transcriptional
partner from HIF-1alpha-dependent to P53-dependent manner
[16]. P53-dependent cell death is a major reason of fetal brain
damage including hemorrhage [12, 13, 14, 15]. To understand the
role of above phosphorylated ATF2, we further investigated the link
between ATF2 and P53. Ischemic reperfusion phosphorylated JNK1/
2 in the fetal brain was partly suppressed by pretreatment with
PFT-a 3 and 6 hs (Fig. 3c). Furthermore, the phosphorylation of
ATF2 at Thr71 was completely suppressed by PFT-a (Fig. 3c). This
result implied that a P53-dependent phosphorylation of ATF2 at
Thr71 was through the phosphorylated JNK1/2 particularly.
In addition, ischemic reperfusion reduced protein syntheisis
including phosphorylation of mTOR and S6, while they were
increasedwith vaginal LPS precondition (Supplementary Fig.1d). In
contrast, phosphorylation of S6 in the fetal brain was almost sup-
pressed by PFT-a (Fig. 3c). This result suggested that increased
protein synthesis in the LPS plus IR group was also regulated by
p53.
4. Discussion
In the present work, it has been suggested that phosphorylation
of ATF2 was a biomarker of fetal hemorrhage induced by vaginal
LPS plus ischemic reperfusion. How does this phosphorylation of
ATF2 occur in the fetal brain? An evolving relationship between
ATF2, HIF-1a and P53 should be very interesting in the fetal brain.
Phosphorylation of ATF2 is reported to have not only P53-
independent transcriptional activity but also a functional associa-
tion with P53 [29,31]. Stable levels of ATF2 regulate transcriptional
activity of HIF-1a by competing with P53 [32]. There was a novel
link between ATF2-P53-JNK1-HIF-1a such as it has documented in
colorectal cancer [33]. Moreover, P53 inhibitor experiments sug-
gested that phosphorylation of ATF2 at Thr71 needed P53 (Fig. 3c).
We proposed that this P53-dependent phosphorylation of ATF2 at
Thr71 in the LPS group may be a speciﬁc sensitive signal of fetal
brain response to IR. A possible explaining is: Ischemic reperfusion
induced HIF-1a-dependent to P53-dependent transcriptional
regulation manner [16]. Vaginal LPS was through cell signaling
pathway to regulate cytokine expression including TNF-a to
sensitize fetal brain (Supplementary Fig. 1e). As well known, LPS
induced inﬂammatory reaction has two aspects: repair and brain
Fig. 1. Vaginal LPS might increase the vulnerability of fetal brain damage response to ischemic reperfusion. (a) The mouse model used in the present work. (b) Whole fetal
brain, (c) negative hemorrhage (no treatment) and (d) positive hemorrhage (red dose). (e) Relative percent of hemorrhage incidence under indicated conditions. Numbers at the top
of column mean the positive hemorrhage/total number of fetal brain. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
Fig. 2. Vaginal LPS induced local inﬂammation but not changes fetal heart rate in response to ischemic reperfusion. (a) Vaginal LPS induced inﬂammatory cell was present at
the junction between the vagina and uterus. HE staining (20 x). Bar length: 100 mm. (beh) Fetal electrocardiograph data of (b) mother mouse's heart beat rate, (c) 1st ischemia, (d)
1st reperfusion, (e) 2nd ischemia, (f) 2nd reperfusion, (g) 3rd ischemia and (h) 3rd reperfusion. (i) Phosphorylation of AKT was measured using total AKT under indicated conditions.
(n ¼ 3 fetuses derived from at least two pregnant mice). (j) IL-6 (white column), G-CSF (black column) and GM-CSF (grey column) were detected in the plasma of maternal mice
within 30 min after IR. Compared with the positive controls and negative control, absorbance at 450 nm less than 0.20 was considered as negative (n ¼ 6). LPS means the maternal
plasma from 3 mg LPS group mice. (k) Vaginal LPS increased TNF-amRNA level in fetal brain (n ¼ 5 from at least 3 individual pregnant mice). This result suggested that vaginal LPS
precondition sensitized the fetal brain via inﬂammatory reaction. Student's t test (two tailed for independent samples) was used for two group comparison, and KruskaleWallis
one-way ANOVA was used for multiple group comparison. p < 0.05 indicated as a single star and p < 0.01 indicated as two stars.
Y. Dong et al. / Biochemical and Biophysical Research Communications 468 (2015) 228e233 231
Fig. 3. Vaginal LPS induced Phosphorylation of ATF2 at Thr71 in response to ischemic reperfusion which was blocked by PFT-a in the fetal brain. (a) Only with vaginal LPS
precondition, the phosphorylation of ATF2 at Thr71 appeared within 30 min response to ischemic reperfusion. (b) The summary of phosphorylation of JNK1/2 and ATF2 compared
with beta-actin. (n ¼ 5 fetuses from at least 3 individual pregnant mice). (c) Pre-treatment mice with PFT-a at 6 h (lane 3 and 5) or 3 h (lane 2 and 4) before ischemic reperfusion, it
blocked phosphorylation of ATF2, completely. (d) The summary of Western blot data (n ¼ 5 fetuses from at least 3 individual pregnant mice). Student's t test (two tailed for in-
dependent samples) was used for two group comparison, and KruskaleWallis one-way ANOVA was used for multiple group comparison. p < 0.05 indicated as a single star and
p < 0.01 indicated as two stars.
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that LPS induced inﬂammation has a neuroprotective role in the
fetal brain [19,34]. Under vaginal LPS precondition, functional p53
in response to ischemic reperfusion who induced fetal brain dam-
age triggered an ATF2-dependent rescue system [9,28,29] (Fig. 3a),
because phosphorylated ATF2 become stable and recovers the
balance between HIF-1a and P53 [32,33]. However, this repair
process increased the vulnerability of hemorrhage (Fig. 1e).
Recently, there was a vast improvement in perinatal care, such
as genetic investigation to diagnose congenital anomaly. However,
the vulnerability of cerebral palsy remains to be about 2% in the
world [20,35,36]. Severe cases of cerebral palsy were mainly
occurred by cerebral hemorrhage during gestation. However, fetal
brain hemorrhage is difﬁcult to diagnose in uterus [19]. Until now,
there is no real-time monitoring technology to identify these
vulnerable patients. Moreover, little is known of the pathophysi-
ology of cerebral hemorrhage during gestation making it harder to
establish a prophylactic treatment [30]. We have attempted to
propose the usage of FECG to monitor the fetal condition together
with the evaluation of ATF2 as a biomarker. This combination will
possibly allow us to understand the underlying mechanisms
behind fetal brain damage.
5. Conclusion
Vaginal LPS administration increased the risk of brain hemor-
rhage in response to IR and triggered P53-dependent ATF2
phosphorylation.
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